Relationship between manganese superoxide dismutase gene Val16Ala polymorphism and susceptibility to prostate cancer: a Meta-analysis
10.3760/cma.j.cn115355-20200529-00288
- VernacularTitle:锰超氧化物歧化酶基因Val16Ala多态性与前列腺癌易感性关系的Meta分析
- Author:
Xinxin XIA
1
;
Yang WU
;
Zhidong PEI
Author Information
1. 郑州大学附属洛阳中心医院肿瘤科，河南 洛阳 471000
- Keywords:
Prostatic neoplasms;
Superoxide dismutase;
Polymorphism, single nucleotide;
Meta-analysis
- From:
Cancer Research and Clinic
2021;33(9):692-696
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the relationship between manganese superoxide dismutase (MnSOD) gene Val16Ala polymorphism and the susceptibility to prostate cancer.Methods:All literatures related to MnSOD gene polymorphism and susceptibility to prostate cancer were retrieved from PubMed, Embase, China Knowledge Network and Wanfang databases. The retrieval time was from the database establishment to September 19, 2018. Literature screening and data extraction were independently done by 2 investigators, and Meta-analysis was performed by using Stata 12.0 software.Results:A total of 17 studies were included in the final analysis, including 7 101 prostate cancer cases and 9 146 healthy controls (people working at hospital and the ordinary people). The results of Meta-analysis showed that MnSOD gene Val16Ala polymorphism was not associated with susceptibility to prostate cancer under the homozygous model ( OR = 1.12, 95% CI 1.02-1.23, P = 0.435), heterozygous model ( OR = 1.14, 95% CI 1.05-1.24, P = 0.765), dominant model ( OR = 1.14, 95% CI 1.05-1.23, P = 0.552) and allele comparison model ( OR = 1.07, 95% CI 1.02-1.12, P = 0.106). Conclusion:There may not be the relationship between MnSOD gene Val16Ala polymorphism and the susceptibility to prostate cancer.
